Adrien SAMSON

Adrien joined EuropaBio, the leading trade association for Europe’s biotechnology industry, in 2022 to support the association work on rare diseases and cell & gene therapies. Adrien now leads the development and implementation of the association's policy and advocacy strategy on healthcare biotech issues. Adrien works with a diverse range of stakeholders, including policymakers, regulators, industry representatives, patient groups, and research organizations, to promote the benefits and potential of biotech for health and society.